Novo Nordisk faces competition from Eli Lilly in new therapeutic areas. Read why I rate NONOF stock as a hold.

Hershey's stock has faced challenges due to excessive price increases and rising cocoa costs, impacting volumes and margins.

The VanEck CLO ETF maintained its conservative positioning amid rich valuations and a tightening basis between higher and ...

Read about activist investor Starboard Value's bullish outlook on Salesforce's valuation and potential to exceed the Rule of ...

Zeta Global Holdings received an Overweight rating by KeyBanc as the investment firm initiated coverage on the marketing ...

Ford's Q3 sales report looked promising in terms of volumes. Check out an educated guess on what the main numbers of F ...

The Fed easing monetary conditions impacts cell tower REITs considerably given the capital intensity of investments and the ...

Discover the potential for growth in MLP as the company develops land with the potential to increase its share price ...

TSMC's stock has surged 105.15% since my strong buy recommendation in November 2023. Read why I maintain my strong buy rating ...

Adams Diversified Equity Fund provides an investor with a pretty plain S&P 500 Index-like exposure in a CEF wrapper. Click ...

Nvidia Corporation's uptrend, robust technical indicators, and solid fundamentals make it a buy with potential for growth and ...

Euroseas Ltd. benefits from favorable market conditions, with growth in Q2 2024 and a strong fleet expansion strategy, but ...